{"id":2924,"date":"2020-06-26T15:19:00","date_gmt":"2020-06-26T19:19:00","guid":{"rendered":"https:\/\/u15.ca\/impact-stories\/nouveaux-essais-cliniques-pour-traiter-la-covid-19\/"},"modified":"2022-10-13T12:49:30","modified_gmt":"2022-10-13T16:49:30","slug":"nouveaux-essais-cliniques-pour-traiter-la-covid-19","status":"publish","type":"impact-stories","link":"https:\/\/u15.ca\/fr\/impact-stories\/nouveaux-essais-cliniques-pour-traiter-la-covid-19\/","title":{"rendered":"Nouveaux essais cliniques pour traiter la COVID-19"},"content":{"rendered":"<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/u15.ca\/wp-content\/uploads\/2022\/08\/laval-colour.png\" style=\"width: 175px; height: 72px; margin-left: 10px; margin-right: 10px; float: left;\" \/>Le Dr Alexis Turgeon, intensiviste, chercheur du CHU de Qu\u00e9bec \u0096 Universit\u00e9 Laval (CHU-UL) et professeur \u00e0 la Facult\u00e9 de m\u00e9decine de l\u0092Universit\u00e9 Laval, a re\u00e7u un financement de pr\u00e8s de 2,2 M$ des Instituts de recherche en sant\u00e9 du Canada (IRSC) pour tester l\u0092efficacit\u00e9 du plasma de convalescents et des anticoagulants chez les patients atteints de la COVID-19 admis aux soins intensifs.<\/p>\n<p>Le premier traitement, qui consiste \u00e0 administrer le plasma de patients gu\u00e9ris de la COVID-19, vise \u00e0 donner des anticorps humains pour ainsi neutraliser le virus. Cet essai clinique se fait en collaboration avec H\u00e9ma-Qu\u00e9bec et la Soci\u00e9t\u00e9 canadienne du sang, les deux organisations responsables de la distribution des produits sanguins au Canada&#8230;.<\/p>\n<p><a href=\"https:\/\/nouvelles.ulaval.ca\/recherche\/nouveaux-essais-cliniques-pour-traiter-la-covid-19-c523f35a3d8d4688efca71243504afb8?sourceOrganizationKey=ulaval\" target=\"_blank\" rel=\"noopener\">https:\/\/nouvelles.ulaval.ca\/recherche\/nouveaux-essais-cliniques-pour-traiter-la-covid-19-c523f35a3d8d4688efca71243504afb8?sourceOrganizationKey=ulaval<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Dr Alexis Turgeon, intensiviste, chercheur du CHU de Qu\u00e9bec \u0096 Universit\u00e9 Laval (CHU-UL) et professeur \u00e0 la Facult\u00e9 de m\u00e9decine de l\u0092Universit\u00e9 Laval, a re\u00e7u un financement de pr\u00e8s de 2,2 M$ des Instituts de recherche en sant\u00e9 du Canada (IRSC) pour tester l\u0092efficacit\u00e9 du plasma de convalescents et des anticoagulants chez les patients [&hellip;]<\/p>\n","protected":false},"featured_media":2118,"template":"","geography":[],"industry":[1548],"topic":[1487,1517],"audience":[],"institution":[1395],"impact-story-tags":[],"class_list":["post-2924","impact-stories","type-impact-stories","status-publish","has-post-thumbnail","hentry","industry-recherche","topic-covid-19-3","topic-traitement","institution-universite-laval-3"],"acf":[],"_links":{"self":[{"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/impact-stories\/2924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/impact-stories"}],"about":[{"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/types\/impact-stories"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/media\/2118"}],"wp:attachment":[{"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/media?parent=2924"}],"wp:term":[{"taxonomy":"geography","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/geography?post=2924"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/industry?post=2924"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/topic?post=2924"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/audience?post=2924"},{"taxonomy":"institution","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/institution?post=2924"},{"taxonomy":"impact-story-tags","embeddable":true,"href":"https:\/\/u15.ca\/fr\/wp-json\/wp\/v2\/impact-story-tags?post=2924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}